The rise and fall of Dimebon.
Bezprozvanny
Ilya
I
Department of Physiology, University of Texas Southwestern Medical Center, Dallas, TX, USA. Ilya.Bezprozvanny@UTSouthwestern.edu
D000544:Alzheimer Disease / Q000188:drug therapy* / Q000503:physiopathology; D000818:Animals; D018849:Controlled Clinical Trials as Topic; D006801:Humans; D006816:Huntington Disease / Q000188:drug therapy* / Q000503:physiopathology; D007211:Indoles / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use; D057051:Product Recalls and Withdrawals; D011969:Receptors, Histamine H1 / Q000187:drug effects / Q000378:metabolism; D011985:Receptors, Serotonin / Q000187:drug effects / Q000378:metabolism; D012426:Russia; D017211:Treatment Failure
D007211:Indoles; D011969:Receptors, Histamine H1; D011985:Receptors, Serotonin; C097216:serotonin 6 receptor; C010119:latrepirdine